Literature DB >> 14610109

Long-term evolution of anti-INFbeta antibodies in IFNbeta-treated MS patients: the London, Canada, MS Clinic experience.

Marcelo Kremenchutzky1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14610109     DOI: 10.1212/01.wnl.0000097294.59963.0e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  2 in total

Review 1.  Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis.

Authors:  Per Soelberg Sorensen
Journal:  CNS Drugs       Date:  2022-05-19       Impact factor: 6.497

Review 2.  Interferon-beta-1b: a review of its use in relapsing-remitting and secondary progressive multiple sclerosis.

Authors:  Paul L McCormack; Lesley J Scott
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.